Literature DB >> 1498147

Pacing requirements after orthotopic heart transplantation: incidence and related factors.

J A Montero1, M Anguita, M Concha, A Villarrubia, J García, J M Arizón, F Calleja, F Vallés.   

Abstract

To assess the incidence of severe bradyarrhythmia and pacing requirements after orthotopic heart transplantation, as well as the possible causal mechanisms, we have reviewed our experience on 52 consecutive transplant patients. The overall incidence of bradyarrhythmia requiring pacing for at least 24 hours after transplantation was 27% (14 patients). The conditions of three of them required pacing for less than 1 week; the conditions of the other 11 patients (21%) required pacing for more than 1 week. Normal sinus rhythm resumed in all but four patients within 3 weeks; a permanent pacemaker was implanted in these four patients (7.6% of all 52 patients and 28% of patients requiring temporary pacing). Late complete heart block associated with acute rejection developed in two patients whose conditions required implantation of a permanent pacemaker. The age and sex of the recipient and donor were similar for patients with or without bradyarrhythmia. The percentage of patients with or without bradyarrhythmias taking amiodarone before transplantation (57% and 46%, respectively), total ischemic time (133 +/- 33 and 123 +/- 37 minutes, respectively), and cardiopulmonary bypass time (117 +/- 17 and 132 +/- 65 minutes, respectively) were not significantly different for either group of patients. The initial temperature of cardioplegic solution for organ storage and the preimplantation myocardial temperature were, however, significantly lower in patients whose conditions required pacing immediately after transplantation than in those whose conditions did not require pacing (5.3 +/- 1.7 degrees C versus 6.5 +/- 1.5 degrees C, p less than 0.05, and 3.9 +/- 1.6 degrees C versus 5.7 +/- 2.6 degrees C, p less than 0.01, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1498147

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

Review 1.  Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients.

Authors:  Douglas L Jennings; Brandon Martinez; Sheila Montalvo; David E Lanfear
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

2.  Posttransplant pacemaker placement: case series and review.

Authors:  Mark A Thompson; Hamang Patel
Journal:  Ochsner J       Date:  2010

3.  Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality.

Authors:  Lauren B Cooper; Robert J Mentz; Leah B Edwards; Amber R Wilk; Joseph G Rogers; Chetan B Patel; Carmelo A Milano; Adrian F Hernandez; Josef Stehlik; Lars H Lund
Journal:  J Heart Lung Transplant       Date:  2016-07-17       Impact factor: 10.247

4.  Risk factors and survival of patients with permanent pacemaker implantation after heart transplantation.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Andreas O Doesch; Philipp Ehlermann; Hugo A Katus; Edgar Zitron
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

5.  Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Arjang Ruhparwar; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Hugo A Katus; Andreas O Doesch
Journal:  Drug Des Devel Ther       Date:  2017-06-19       Impact factor: 4.162

6.  Combined amiodarone and digitalis therapy before heart transplantation is associated with increased post-transplant mortality.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Andreas O Doesch; Philipp Ehlermann; Hugo A Katus; Edgar Zitron
Journal:  ESC Heart Fail       Date:  2020-07-01

7.  Amiodarone Use Prior to Cardiac Transplant Impacts Early Post-Transplant Survival.

Authors:  Salman S Allana; Furqan A Rajput; Jason W Smith; Lucian Lozonschi; Jinn-Ing Liou; Maryl Johnson; Takushi Kohmoto; Ravi Dhingra
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-19       Impact factor: 3.727

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.